Hospital News and Research

RSS

Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue

Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that the Defense Department's Armed Forces Institute of Regenerative Medicine will fund the Phase IIb clinical trial of the company's flagship StrataGraft living human skin substitute tissue.

8 Oct 2010

Correcting vitamin D deficiency before orthopedic surgery improves patient outcome: Study

Almost 50 percent of patients undergoing orthopedic surgery have vitamin D deficiency that should be corrected before surgery to improve patient outcomes, based on a study by researchers at Hospital for Special Surgery (HSS) in New York City. Vitamin D is essential for bone healing and muscle function and is critical for a patient's recovery. The study appears in the October issue of The Journal of Bone and Joint Surgery.

8 Oct 2010

Presbyterian Hospital collaborates with New York Center for Autism to establish Institute for Brain Development

NewYork-Presbyterian Hospital, along with its affiliated medical schools Columbia University College of Physicians and Surgeons and Weill Cornell Medical College, announced its collaboration with the New York Center for Autism to establish the Institute for Brain Development, a comprehensive, state-of-the-art institute dedicated to addressing the pressing clinical needs of individuals living with autism spectrum disorders and other developmental disorders of the brain, across their lifespan.

8 Oct 2010

Cincinnati Children's Hospital Medical Center named Centers of Excellence for Molecular Hematology

Cincinnati Children's Hospital Medical Center has been named one of five national Centers of Excellence for Molecular Hematology to find new gene and cell therapies for inherited diseases affecting blood cells.

8 Oct 2010

Phase I study of Shigella dysenteriae bioconjugate vaccine meets primary, secondary endpoints

GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.

8 Oct 2010

GE Healthcare announces successful completion of vendor neutral DI-r

GE Healthcare announced today the successful completion of a vendor neutral Digital Imaging Repository that connects hospitals and medical centers throughout Southwestern Ontario, Canada, enabling the sharing of patient health data across the region. For the first time in Ontario's history, 26 hospital organizations in the Erie St. Clair and South West Local Health Integration Networks are able to share filmless diagnostic image exams between their facilities.

8 Oct 2010

IMNG relaunches websites for Internal Medicine News, Hospitalist News

International Medical News Group, an Elsevier company that provides medical news to physicians, today announced the relaunch of its websites for Internal Medicine News (www.internalmedicinenews.com) and Hospitalist News.

8 Oct 2010

Abiraterone Phase III clinical data to be presented at ESMO meeting

Attendees at next week's European Society of Medical Oncology (ESMO) meeting in Milan will be presented with top-line Phase III Clinical Trials data on Abiraterone in the treatment of castration-resistant prostate cancer.

8 Oct 2010

MRSA pathogen influences U.S. physician drug selection for treating skin structure infections

Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that methicillin-resistant Staphylococcus aureus (MRSA) is the most concerning pathogen to surveyed U.S. physicians with regard to their treatment of skin and skin structure infections.

8 Oct 2010

Study finds boosting mitochondria may delay onset of Parkinson's disease

In a study that sheds new light on the causes of Parkinson's disease, researchers report that brain cells in Parkinson's patients abandon their energy-producing machinery, the mitochondria. A shutdown in fuel can have devastating effects on brain cells, which consume roughly 20 percent of the body's energy despite making up only 2 percent of body weight.

8 Oct 2010

Researchers identify risk factors that cause bicycling injuries

The streets of New York City can be dangerous for bicyclists, but they can be especially risky for young adult male bicyclists who don't wear helmets, have too much to drink, or are listening to music through earphones, a group of investigators from New York City's Bellevue Hospital reported at the 2010 Annual Clinical Congress of the American College of Surgeons.

8 Oct 2010

IV ibuprofen effective in reducing fever in hospitalized patients

Cumberland Pharmaceuticals Inc. today announced the publication of data affirming the safety and efficacy of Caldolor (ibuprofen) Injection in treating fever in critically ill and non-critically ill adults. Published in the peer-reviewed journal Critical Care, the study showed that IV ibuprofen was significantly more effective at reducing fever in hospitalized patients than placebo.

8 Oct 2010

Childhood abuse may lead to physiological consequences later in life

Seemingly healthy adults, if they were abused or neglected during childhood, may suffer physiological consequences decades later. In research published online last week by the journal Neuropsychopharmacology, a team led by psychiatrists at Brown University and Butler Hospital found that healthy adults who reported being mistreated as kids appear to have an elevated inflammatory response to stress compared to adults who had happier childhoods.

8 Oct 2010

U.S. to provide $120M for Haitian rebuilding, rubble removal; Haiti Commission approves 18 projects worth $777M

The U.S. on Wednesday announced that it will contribute $120 million to the Haiti Recovery Fund, the New York Times reports. Cheryl Mills, chief of staff to Secretary of State Hillary Rodham Clinton, announced the funding during the third meeting of the Interim Haiti Recovery Commission (IHRC).

8 Oct 2010

StemCells provides update on PMD Phase I clinical trial

StemCells, Inc. today provided an update on its ongoing Phase I clinical trial in Pelizaeus-Merzbacher Disease (PMD), a fatal myelination disorder that afflicts male children.

8 Oct 2010

Arthritis Foundation launches new initiatives on World Arthritis Day

The already staggering social and economic impact of arthritis in the United States is set to explode during the coming decades, says the Arthritis Foundation in response to a Centers for Disease Control and Prevention (CDC) report published in the Oct. 8 issue of Morbidity and Mortality Weekly Report, which coincides with World Arthritis Day on Tuesday, Oct. 12.

8 Oct 2010

Royal Philips Electronics introduces IntelliVue MX800 patient monitoring system

Royal Philips Electronics today introduced the IntelliVue MX800 patient monitoring system, a new dimension in patient care that provides immediate access to comprehensive patient information directly at the monitor. In addition to displaying and recording traditional data such as patient vital signs, the IntelliVue MX800 offers direct access to patient information from almost any system on a hospital's IT infrastructure.

From Philips Healthcare 8 Oct 2010

Hospital News and Research

Defense Department's AFIRM to fund Stratatech's Phase IIb clinical trial of StrataGraft tissue

Correcting vitamin D deficiency before orthopedic surgery improves patient outcome: Study

Presbyterian Hospital collaborates with New York Center for Autism to establish Institute for Brain Development

Cincinnati Children's Hospital Medical Center named Centers of Excellence for Molecular Hematology

Phase I study of Shigella dysenteriae bioconjugate vaccine meets primary, secondary endpoints

GE Healthcare announces successful completion of vendor neutral DI-r

IMNG relaunches websites for Internal Medicine News, Hospitalist News

Abiraterone Phase III clinical data to be presented at ESMO meeting

MRSA pathogen influences U.S. physician drug selection for treating skin structure infections

Study finds boosting mitochondria may delay onset of Parkinson's disease

Researchers identify risk factors that cause bicycling injuries

IV ibuprofen effective in reducing fever in hospitalized patients

Childhood abuse may lead to physiological consequences later in life

U.S. to provide $120M for Haitian rebuilding, rubble removal; Haiti Commission approves 18 projects worth $777M

StemCells provides update on PMD Phase I clinical trial

Arthritis Foundation launches new initiatives on World Arthritis Day

Royal Philips Electronics introduces IntelliVue MX800 patient monitoring system

Matchmaker function may help cardiologists understand the natural repair process after heart attacks

Children who have asthma are less likely to smoke during teen years

Device maker study: Hospital middlemen arrangement wastes billions

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News